Michael Joseph Golembiewski Seelos Therapeutics, Inc. (SEEL) insider trading activity

SEEL Quotes by TradingView

Michael Joseph Golembiewski is Chief Financial Officer of SEELOS THERAPEUTICS, INC.. Currently has a direct ownership of 86,869 shares of SEEL, which is worth approximately $17,373. The most recent transaction as insider was on Feb 29, 2024, when has been sold 417 shares (Common Stock) at a price of $1.1 per share, resulting in proceeds of $458. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 86.9K
0% 3M change
16.06% 12M change
Total Value Held $17,373

Michael Joseph Golembiewski Transaction History

Date Transaction Value Shares Traded Shares Held Form
Feb 29 2024
BUY
Grant, award, or other acquisition
$458 $1.1 p/Share
417 Added 0.48%
86,869 Common Stock
Nov 30 2023
BUY
Open market or private purchase
$100,430 $1.21 p/Share
83,000 Added 48.98%
86,450 Common Stock
Aug 31 2023
BUY
Grant, award, or other acquisition
$7,750 $0.62 p/Share
12,500 Added 10.78%
103,487 Common Stock
Feb 28 2023
BUY
Grant, award, or other acquisition
$8,375 $0.67 p/Share
12,500 Added 12.08%
90,987 Common Stock
Feb 28 2022
BUY
Grant, award, or other acquisition
$11,250 $0.9 p/Share
12,500 Added 13.74%
78,487 Common Stock
MJG

Michael Joseph Golembiewski

Chief Financial Officer
New York, NY

Track Institutional and Insider Activities on SEEL

Follow SEELOS THERAPEUTICS, INC. and customize your updates to receive the information that matters most to you.

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells SEEL shares.

Notify only if

Insider Trading

Get notified when an Seelos Therapeutics, Inc. insider buys or sells SEEL shares.

Notify only if

News

Receive news related to SEELOS THERAPEUTICS, INC.

Choose your preferred platform and Sign Up 👇 Telegram Email
Track Activities on SEEL